JP Morgan Chase
ASPN icon

JP Morgan Chase’s Aspen Aerogels ASPN Stock Holding History

JP Morgan Chase’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.06M Sell
965,492
-518,253
-35% -$1.75M ﹤0.01% 3761
2025
Q4 		$4.2M Buy
1,483,745
+133,996
+10% +$691K ﹤0.01% 3487
2025
Q3 		$9.39M Buy
1,349,749
+103,243
+8% +$728K ﹤0.01% 2769
2025
Q2 		$7.38M Buy
1,246,506
+639,753
+105% +$3.68M ﹤0.01% 2806
2025
Q1 		$3.88M Buy
606,753
+501,162
+475% +$4.83M ﹤0.01% 3377
2024
Q4 		$1.25M Buy
105,591
+79,901
+311% +$1.36M ﹤0.01% 4465
2024
Q3 		$711K Buy
25,690
+790
+3% +$19.8K ﹤0.01% 4687
2024
Q2 		$594K Buy
24,900
+4,812
+24% +$113K ﹤0.01% 4588
2024
Q1 		$354K Sell
20,088
-14,244
-41% -$210K ﹤0.01% 5013
2023
Q4 		$542K Sell
34,332
-626
-2% -$6.46K ﹤0.01% 4740
2023
Q3 		$301K Sell
34,958
-10,469
-23% -$74.4K ﹤0.01% 4783
2023
Q2 		$358K Sell
45,427
-21,379
-32% -$149K ﹤0.01% 4698
2023
Q1 		$498K Buy
66,806
+23,672
+55% +$235K ﹤0.01% 4507
2022
Q4 		$508K Buy
43,134
+14,997
+53% +$171K ﹤0.01% 4506
2022
Q3 		$259K Buy
28,137
+3,116
+12% +$37.7K ﹤0.01% 4821
2022
Q2 		$247K Buy
25,021
+7,547
+43% +$152K ﹤0.01% 4960
2022
Q1 		$603K Sell
17,474
-15,200
-47% -$493K ﹤0.01% 4583
2021
Q4 		$1.63M Buy
32,674
+19,613
+150% +$1.03M ﹤0.01% 4012
2021
Q3 		$601K Sell
13,061
-22,891
-64% -$907K ﹤0.01% 4621
2021
Q2 		$1.08M Sell
35,952
-30,369
-46% -$620K ﹤0.01% 4241
2021
Q1 		$1.35M Buy
66,321
+9,441
+17% +$199K ﹤0.01% 3999
2020
Q4 		$950K Buy
56,880
+40,626
+250% +$534K ﹤0.01% 4001
2020
Q3 		$179K Sell
16,254
-5,578
-26% -$44.1K ﹤0.01% 4415
2020
Q2 		$143K Buy
+21,832
New +$140K ﹤0.01% 4419
2018
Q4 		– Sell
-6,090
Closed -$28K – 5677
2018
Q3 		$28K Buy
+6,090
New +$29.6K ﹤0.01% 5355
2018
Q2 		– Sell
-31,317
Closed -$134K – 5538
2018
Q1 		$134K Buy
31,317
+3,008
+11% +$14.2K ﹤0.01% 4505
2017
Q4 		$138K Buy
+28,309
New +$132K ﹤0.01% 4548

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

JP Morgan Chase's ASPN Position: Q1 2026 in Review

JP Morgan Chase reduced its Aspen Aerogels (ASPN) stake by 35% in Q1 2026, selling an estimated $1.75M and leaving 965,492 shares worth $3.06M. The position accounts for ﹤0.01% of the portfolio, ranked #3761.

JP Morgan Chase first reported a position in ASPN in Q4 2017 and has held it in 27 quarters since. The position peaked at $9.39M in Q3 2025. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • JP Morgan Chase held 965,492 shares of Aspen Aerogels worth $3.06M as of Q1 2026.
  • JP Morgan Chase sold 518,253 Aspen Aerogels shares in Q1 2026, an estimated $1.75M.
  • Aspen Aerogels made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3761 holding.
  • JP Morgan Chase first reported a position in Aspen Aerogels in Q4 2017 and has held it in 27 quarters since.
  • JP Morgan Chase's Aspen Aerogels position peaked at $9.39M in Q3 2025.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.